Interpretation of MCV 98.1 fL (high) and MCHC 29.9 g/dL (low)
Your combination of borderline-high MCV (98.1 fL) with low MCHC (29.9 g/dL) suggests early iron deficiency or functional iron deficiency, and you need immediate iron studies (serum ferritin and transferrin saturation) to confirm this diagnosis.
Understanding Your Red Cell Indices
Your MCV of 98.1 fL is at the upper limit of normal (typically 80-100 fL), while your MCHC of 29.9 g/dL is definitively low (normal range 32-36 g/dL). This specific pattern is clinically significant:
Low MCHC: The Primary Concern
Low MCHC indicates that your red blood cells contain less hemoglobin than they should relative to their size. MCHC is a late marker of iron deficiency 1, meaning iron depletion has progressed enough to affect hemoglobin synthesis within red cells. The guideline framework emphasizes that low MCV (which you don't have yet) usually suggests deficiencies of iron, folic acid, and vitamin B12 1, but your pattern shows MCHC dropping before MCV becomes frankly low—this is characteristic of evolving iron deficiency.
Recent evidence demonstrates that low MCHC (< 32 g/dL) has significant clinical implications beyond anemia classification, including associations with cardiovascular disease 2 and increased mortality in critically ill patients 3. In dialysis patients, low MCHC independently predicted nonatherosclerotic cardiovascular disease and correlated with cardiac structural changes 2.
Borderline-High MCV: The Confounding Factor
Your slightly elevated MCV creates a mixed picture. The borderline macrocytosis could be:
- Masking more severe microcytosis from iron deficiency (if your MCV would otherwise be much lower)
- Concurrent B12/folate deficiency competing with iron deficiency
- Alcohol use, liver disease, or hypothyroidism elevating MCV
- Reticulocytosis (young red cells are larger) if your bone marrow is responding to blood loss
This mixed pattern is clinically important because the elevated MCV can artificially maintain hemoglobin levels despite iron deficiency 4, potentially delaying diagnosis.
Immediate Diagnostic Workup Required
You need the following tests immediately:
- Serum ferritin - assesses total body iron stores (absolute iron deficiency if < 30 ng/mL in general population, < 100 ng/mL in inflammatory states)
- Transferrin saturation (TSAT) - evaluates iron available for erythropoiesis (< 20% suggests iron deficiency)
- Complete blood count with reticulocyte count - assesses bone marrow response
- Vitamin B12 and folate levels - to explain the borderline-high MCV
- Comprehensive metabolic panel and thyroid function - to identify other causes of macrocytosis
The guideline explicitly states that iron deficiency in patients without obvious blood loss should prompt careful assessment for gastrointestinal bleeding 1. This is critical—occult GI bleeding is a common cause of iron deficiency in adults.
Clinical Significance and Risk Stratification
Cardiovascular Risk
Low MCHC carries prognostic significance beyond simple anemia. In the most recent high-quality study, each unit increase in MCHC was associated with 14% lower mortality risk (HR: 0.86,95% CI: 0.83-0.89) in critically ill patients 3. Among dialysis patients, low MCHC predicted cardiovascular events through associations with left ventricular hypertrophy and atrial overload 2.
Functional Implications
Low MCHC reflects inadequate hemoglobin concentration in red cells, reducing oxygen-carrying capacity even when hemoglobin levels appear acceptable. This functional iron deficiency can cause:
- Fatigue and reduced exercise tolerance
- Impaired cognitive function
- Decreased quality of life
- Progression to overt anemia if untreated
Common Pitfalls to Avoid
- Don't dismiss borderline values: Your MCV is "high-normal" and MCHC is "low-abnormal"—this combination is not normal and requires investigation
- Don't assume normal hemoglobin excludes iron deficiency: Elevated MCV can mask anemia by maintaining hemoglobin despite iron deficiency 4
- Don't overlook mixed deficiencies: You may have both iron deficiency (causing low MCHC) and B12/folate deficiency (causing high MCV)
- Don't forget inflammation: Inflammatory states cause functional iron deficiency with low TSAT despite adequate ferritin 1
Treatment Approach (Pending Confirmation)
Once iron deficiency is confirmed:
- Oral iron supplementation (ferrous sulfate 325 mg daily) for mild deficiency without malabsorption
- Investigate and treat underlying cause (especially GI bleeding if no obvious source)
- Recheck CBC in 4-6 weeks to confirm response (reticulocyte count should rise within 1-2 weeks)
- Consider IV iron if oral iron fails, malabsorption present, or ongoing losses exceed oral replacement capacity
If B12/folate deficiency is confirmed, address this concurrently with appropriate supplementation.
The key message: Your lab pattern is not normal and requires prompt evaluation with iron studies and assessment for underlying causes, particularly occult bleeding.